Amgen Usa Inc
Rank #649 of 1,000 by FY2025 federal contract value
FY2025 contract value
$89,869,425
Oct 1, 2024 – Sep 30, 2025
FY2024 contract value
$129,850,670
FY2023 contract value
$0
Top agency (FY2025)
Department of Health and Human Services
$89,932,933
Company profile
- Legal name (as listed)
- AMGEN USA INC
- UEI
- Y6NEW42XK544
- DUNS
- Not listed
- Headquarters
- Not listed
- Business types
- Not listed
Contract value trend, FY2023 – FY2025
| Fiscal year | Contract value | Change vs prior year |
|---|---|---|
| FY2023 | $0 | — |
| FY2024 | $129,850,670 | — |
| FY2025 | $89,869,425 | -30.8% |
FY2025 breakdowns
Top 10 in each category by FY2025 contract value.
Top awarding agencies
| Department of Health and Human ServicesHHS | $89,932,933 |
| Department of Veterans AffairsVA | -$63,508 |
Top places of performance (states)
| CaliforniaCA | $89,932,933 |
| TennesseeTN | -$63,508 |
Top industries (NAICS)
| Research and Development in Biotechnology (except Nanobiotechnology)541714 | $89,932,933 |
| Pharmaceutical Preparation Manufacturing325412 | -$63,508 |
Top product & service codes (PSC)
| HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENTAN13 | $89,932,933 |
| DRUGS AND BIOLOGICALS6505 | -$63,508 |
Contract awards
Up to 20 awards with activity in FY2025, newest start date first. Amounts are individual award obligations, not company totals.
CONT_AWD_75A50124C00011_7505_-NONE-_-NONE-
$811,924
Awarding agency: Department of Health and Human Services
Description: VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS, PHYSICAL, RADIOLOGIC AND NUCLEAR EXPOSURES.
Start date: Mar 12, 2024
NAICS: —
PSC: —
Place: CA
CONT_AWD_36C26024F0036_3600_36F79721D0086_3600
$65,210
Awarding agency: Department of Veterans Affairs
Description: TAVNEOS (AVACOPAN)
Start date: Oct 1, 2023
NAICS: —
PSC: —
Place: TN
CONT_AWD_75A50122C00065_7505_-NONE-_-NONE-
$839,875,190
Awarding agency: Department of Health and Human Services
Description: TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.
Start date: Sep 30, 2022
NAICS: —
PSC: —
Place: CA
NAICS and PSC are not reported for these awards in USAspending.
Source: USAspending.gov. Company totals are sums of all contract obligations across the company's USAspending recipient records for each fiscal year. This page is not affiliated with or endorsed by the U.S. government.